For in vitro diagnostic use. Others Elecsys CA 72-4 IVD Elecsys® CA 72-4 CPS_000450 09005706188 CA 72-4 Elecsys E2G 300 V2 Elecsys CA 72-4 07613336179734 Reagents, kits 100 tests cobas e 402/801 true 09005706190 CA 72-4 Elecsys E2G 300 V2 Elecsys CA 72-4 07613336171530 Reagents, kits 300 tests cobas e 402/801 true 09744525190 CA 72-4 Elecsys E2G 100 V2 Elecsys CA 72-4 07613336217610 Reagents, kits 100 tests cobas e 402/801 true 11776258122 CA 72-4 Elecsys cobas e 100 Elecsys CA 72-4 04015630909803 Reagents, kits 100 tests cobas e 411/601/602 true 09005706214 CA 72-4 Elecsys E2G 300 V2 Elecsys CA 72-4 07613336179741 Reagents, kits 100 tests cobas e 402/801 true 09005692190 CA 72-4 Elecsys cobas e 100 V2 Elecsys CA 72-4 07613336171523 Reagents, kits 100 tests cobas e 411/601/602 true 07324910190 CA 72-4 Elecsys E2G 300 Elecsys CA 72-4 04015630939657 Reagents, kits 300 tests cobas e 402/801 true 09005706500 Elecsys CA 72-4 en 2 FF00000006730A0E FF000000045ACA0E 09005706190 09005706214 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of CA 72‑4 in human serum and plasma. The assay in particular serves as an aid in the therapeutic monitoring of carcinomas of the stomach and ovaries.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09744525500 Elecsys CA 72-4 en 1 FF000000066E3A0E FF000000066E3A0E 09744525190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of CA 72‑4 in human serum and plasma. The assay in particular serves as an aid in the therapeutic monitoring of carcinomas of the stomach and ovaries.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 11776258500 Elecsys CA 72-4 en 15 FF000000045DD10E FF00000000042D0E 11776258122 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of CA 72‑4 in human serum and plasma. The assay in particular serves as an aid in the therapeutic monitoring of carcinomas of the stomach and ovaries.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 09005692500 Elecsys CA 72-4 en 2 FF00000004B4DB0E FF0000000493AF0E 09005692190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of CA 72‑4 in human serum and plasma. The assay in particular serves as an aid in the therapeutic monitoring of carcinomas of the stomach and ovaries.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07324910500 Elecsys CA 72-4 en 5 FF000000045DE20E FF000000016ED90E 07324910190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of CA 72‑4 in human serum and plasma. The assay in particular serves as an aid in the therapeutic monitoring of carcinomas of the stomach and ovaries.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en